ALKERMES | ALKS - Dividendenrendite





Dy Veränderung Datum
AbbVie 3.1 0.19 2026-03
Amgen 2.78 0.17 2026-03
Bristol-Myers Squibb 4.12 3.9 2026-03
Coherus Biosciences 0 0 2025-03
Eli Lilly 0.58 0.16 2025-12
Gilead Sciences 2.29 0.29 2026-03
Heron Therapeutics 0 0 2025-03
J&J 2.16 0.34 2026-03
Merck 2.76 0.36 2026-03
Minerva Neurosciences 0 0 2025-03
Nektar Therapeutics 0 0 2025-03
Otsuka Holdings 1.27 0.19 2026-03
Pfizer 6.36 0.55 2026-03
Regeneron Pharmaceuticals 0.46 0.01 2026-03